Clinical Trial Update: A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846 [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety evaluation of CKD-846 in Benign prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• CKD-846

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Benign Prostate Hypertrophy(BPH) | Phase 1 | Status: COMPLETED